Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q3 FY25 results · Oct–Dec 2024
Divi's Laboratories reported revenue from operations of ₹2,319.00 crore (up 25.0% from Q3 FY24) and net profit of ₹589.00 crore (up 64.5% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,319.00 | 1,855.00 | +25.0% | 2,338.00 | −0.8% |
| Other income | 82.00 | 95.00 | −13.7% | 106.00 | −22.6% |
| Total income | 2,401.00 | 1,950.00 | +23.1% | 2,444.00 | −1.8% |
| Profit before tax | 726.00 | 489.00 | +48.5% | 722.00 | +0.6% |
| Net profit for the period | 589.00 | 358.00 | +64.5% | 510.00 | +15.5% |
| EPS, basic (₹) | 22.20 | 13.50 | +64.4% | 19.20 | +15.6% |
| Net margin (%) | 25.4 | 19.3 | 21.8 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,297.00 | 1,808.00 | +27.0% | 2,302.00 | −0.2% |
| Other income | 82.00 | 94.00 | −12.8% | 105.00 | −21.9% |
| Total income | 2,379.00 | 1,902.00 | +25.1% | 2,407.00 | −1.2% |
| Profit before tax | 730.00 | 490.00 | +49.0% | 735.00 | −0.7% |
| Net profit for the period | 594.00 | 358.00 | +65.9% | 518.00 | +14.7% |
| EPS, basic (₹) | 22.39 | 13.50 | +65.9% | 19.51 | +14.8% |
| Net margin (%) | 25.9 | 19.8 | 22.5 |
Consolidated
- Filed with BSE
- 03 Feb 2025, 17:16 IST
- Board meeting
- 03 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Feb 2025, 17:16 IST
- Board meeting
- 03 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE